The Motley Fool•27 Ekim 2026Rising rates create buying opportunities in dividend stocks like AT&T and Pfizer
The Motley Fool•23 Ekim 2026Pfizer offers a higher dividend yield while Bristol Myers Squibb is seen as safer
The Motley Fool•22 Ekim 2026Bristol Myers Squibb shows steadier revenue growth trajectory than Pfizer